Evidence map›Paper›PMID 39672920›Full record

ArticleEuropean journal of human genetics : EJHG2025

Variants in the AGBL5 gene are responsible for autosomal recessive Retinitis pigmentosa with hearing loss.

Marianthi Karali, Gema García-García, Karolina Kaminska, Alaa AlTalbishi, Francesca Cancellieri, Francesco Testa, Maria Rosaria Barillari, Evangelia S Panagiotou, George Psillas, Veronika Vaclavik and 14 more

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Marianthi Karali *Medical Genetics, Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', 80138, Naples, Italy.
Gema García-García *Molecular, Cellular, and Genomic Biomedicine Group, IIS-La Fe, Valencia, Spain.
Karolina KaminskaInstitute of Molecular and Clinical Ophthalmology Basel, 4031, Basel, Switzerland.ORCID 0000-0002-4720-5527
Alaa AlTalbishiSt John of Jerusalem Eye Hospital, Jerusalem, Palestine.
Francesca CancellieriInstitute of Molecular and Clinical Ophthalmology Basel, 4031, Basel, Switzerland.ORCID 0000-0001-8476-5366
Francesco TestaEye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania 'Luigi Vanvitelli', 80131, Naples, Italy.
Maria Rosaria BarillariDepartment of Mental and Physical Health and Preventive Medicine, University of Campania 'Luigi Vanvitelli', 80138, Naples, Italy.ORCID 0000-0002-5457-1509
Evangelia S Panagiotou1st Department of Ophthalmology, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece.ORCID 0009-0005-9850-784X
George Psillas1st Academic ENT Department, School of Medicine, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece.
Veronika VaclavikJules-Gonin Eye Hospital, Fondation Asile des Aveugles, University of Lausanne, 1004, Lausanne, Switzerland.
Viet H TranJules-Gonin Eye Hospital, Fondation Asile des Aveugles, University of Lausanne, 1004, Lausanne, Switzerland.
Lucas Janeschitz-KrieglDepartment of Ophthalmology, University of Basel, Basel, Switzerland.
Hendrik Pn SchollDepartment of Ophthalmology, University of Basel, Basel, Switzerland.
Manar SalamehSt John of Jerusalem Eye Hospital, Jerusalem, Palestine.
Pilar Barberán-MartínezMolecular, Cellular, and Genomic Biomedicine Group, IIS-La Fe, Valencia, Spain.ORCID 0000-0002-3604-7068
Ana Rodríguez-MuñozUniversity Dr Peset Hospital of Valencia, Valencia, Spain.
Miguel ArmengotUniversity and Polytechnic La Fe Hospital of Valencia, Valencia, Spain.ORCID 0000-0001-8258-6292
Margherita ScarpatoMedical Genetics, Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', 80138, Naples, Italy.ORCID 0009-0006-7367-7911
Roberta ZeuliMedical Genetics, Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', 80138, Naples, Italy.ORCID 0000-0003-1783-3415
Mathieu QuinodozInstitute of Molecular and Clinical Ophthalmology Basel, 4031, Basel, Switzerland.
Francesca SimonelliEye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania 'Luigi Vanvitelli', 80131, Naples, Italy.
Carlo RivoltaInstitute of Molecular and Clinical Ophthalmology Basel, 4031, Basel, Switzerland.ORCID 0000-0002-0733-9950
Sandro BanfiMedical Genetics, Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', 80138, Naples, Italy. banfi@tigem.it.ORCID 0000-0002-6541-8833
José M MillánMolecular, Cellular, and Genomic Biomedicine Group, IIS-La Fe, Valencia, Spain. jose_millan@iislafe.es.ORCID 0000-0002-7211-9129

Funding

Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) AC21_2/00022Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) FPU20/04736Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) PI22/00213
6 · The paper itself

Abstract

The AGBL5 gene encodes for the Cytoplasmic Carboxypeptidase 5 (CCP5), an α-tubulin deglutamylase that cleaves the γ-carboxyl-linked branching point of glutamylated tubulin. To date, pathogenic variants in AGBL5 have been associated only with isolated retinitis pigmentosa (RP). Hearing loss has not been reported in AGBL5-caused retinal disease. In this study, we performed exome sequencing in probands of eight unrelated families from Italy, Spain, Palestine, Switzerland, and Greece. All subjects had a clinical diagnosis of (suspected) Usher syndrome type II for the concurrent presence of RP and post-verbal sensorineural hearing loss (SNHL) that ranged from mild to moderate.We identified biallelic sequence variants in AGBL5 in all analysed subjects. Four of the identified variants were novel. The variants co-segregated with the retinal and auditory phenotypes in additional affected family members. We did not detect any causative variants in known deafness or Usher syndrome genes that could explain the patients' hearing loss. We therefore conclude that SNHL is a feature of a syndromic presentation of AGBL5 retinopathy. This study provides the first evidence that mutations in AGBL5 can cause syndromic RP forms associated with hearing loss, probably due to dysfunction of sensory cilia in the retina and the inner ear.

Indexed as

Hearing Loss, SensorineuralRetinitis PigmentosaAdolescentAdultChildFemaleGenes, RecessiveHumansMaleMiddle AgedMutationPedigreeUsher Syndromes

Identifiers

PMID39672920
PMCPMC12185745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.